1. Acute myeloid leukemia: developing drugs and biological products for treatment : guidance for industry Publication: Silver Spring, MD : Center for Drug Evaluation and Research, October 2022 Subject(s): Biological ProductsDrug Development -- legislation & jurisprudenceGovernment RegulationLeukemia, Myeloid, Acute -- drug therapyUnited StatesUnited States. Food and Drug Administration
